Comprehensive Financial Consultants Institutional, Inc. Viatris Inc Transaction History

Comprehensive Financial Consultants Institutional, Inc.

$259 Million
Q3 2024

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q1 2022 May 11, 2022	SELL	$9.81 - $15.4 $5,140 - $8,069	-524 Closed	0 $0
Q4 2021 Mar 10, 2022	BUY	$12.09 - $14.68 $6,335 - $7,692	524 New	524 $7,000

Others Institutions Holding VTRS

# of Institutions

1,102

Shares Held

933M

Call Options Held

2.71M

Put Options Held

2.4M

Vanguard Group Inc Valley Forge, PA

141M
Shares

$1.75 Billion
0.03% of portfolio
Black Rock Inc. New York, NY

92.7M
Shares

$1.15 Billion
0.02% of portfolio
State Street Corp Boston, MA

63.1M
Shares

$781 Million
0.03% of portfolio
Chris Davis Davis Selected Advisers | Tucson, Az

62.6M
Shares

$776 Million
4.18% of portfolio
Price T Rowe Associates Inc Baltimore, MD

48.8M
Shares

$604 Million
0.07% of portfolio

View Full List

About Viatris Inc

Ticker VTRS
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,212,669,952
Market Cap $15B
Description
Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...

More about VTRS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Comprehensive Financial Consultants Institutional, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Comprehensive Financial Consultants Institutional, Inc. with notifications on news.

Account